Cargando…

Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study

Detalles Bibliográficos
Autores principales:	Pira, Anna, Moltrasio, Chiara, Abeni, Damiano, Corrà, Alberto, Marzano, Angelo Valerio, Caproni, Marzia, Di Zenzo, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060545/ https://www.ncbi.nlm.nih.gov/pubmed/37007791 http://dx.doi.org/10.3389/fmed.2023.1160672

Ejemplares similares

Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
por: Kasperkiewicz, Michael, et al.
Publicado: (2022)

Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis
por: Moro, Francesco, et al.
Publicado: (2022)

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)

The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets
por: Maglie, Roberto, et al.
Publicado: (2023)

A Systematic Review of Treatment Options and Clinical Outcomes in Pemphigoid Gestationis
por: Genovese, Giovanni, et al.
Publicado: (2020)

The Intriguing Links between Psoriasis and Bullous Pemphigoid
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Bullous Pemphigoid: Trigger and Predisposing Factors
por: Moro, Francesco, et al.
Publicado: (2020)

Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience
por: Merli, Martina, et al.
Publicado: (2023)

Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights
por: D’Astolto, Roberto, et al.
Publicado: (2023)

156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset
por: Pira, A., et al.
Publicado: (2023)

Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine
por: Pira, Anna, et al.
Publicado: (2023)

Linear IGA bullous dermatosis potentially triggered by vaccination
por: Corrà, Alberto, et al.
Publicado: (2022)

Bullous Pemphigoid Complicated by Sepsis
por: Shah, Dipal, et al.
Publicado: (2022)

Autoantibody Profile of a Cohort of 54 Italian Patients with Linear IgA Bullous Dermatosis: LAD-1 Denoted as a Major Auto-antigen of the Lamina Lucida Subtype
por: COZZANI, Emanuele, et al.
Publicado: (2020)

Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin
por: Chouchane, Karim, et al.
Publicado: (2021)

Treatment of Autoimmune Bullous Diseases During Pregnancy and Lactation: A Review Focusing on Pemphigus and Pemphigoid Gestationis
por: Genovese, Giovanni, et al.
Publicado: (2020)

Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening
por: Di Zenzo, Giovanni, et al.
Publicado: (2022)

IgE autoantibodies in serum and skin of non‐bullous and bullous pemphigoid patients
por: Lamberts, A., et al.
Publicado: (2020)

The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations
por: Kridin, Khalaf, et al.
Publicado: (2018)

May bullous pemphigoid be worsened by COVID-19 vaccine?
por: Cozzani, Emanuele, et al.
Publicado: (2022)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Wang, Si-Hang, et al.
Publicado: (2021)

Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature
por: Bech, Rikke, et al.
Publicado: (2018)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Bullous Pemphigoid Presenting with Esophagitis Dissecans Superficialis
por: Inoue, Kunimitsu, et al.
Publicado: (2017)

Bullous Pemphigoid in a Patient Treated with Pembrolizumab
por: Hara, Kanako, et al.
Publicado: (2019)

Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
por: Khil'chenko, Stanislav, et al.
Publicado: (2020)

The Bidirectional Association Between Bullous Pemphigoid and Psoriasis: A Population-Based Cohort Study
por: Kridin, Khalaf, et al.
Publicado: (2020)

Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative
por: Rosińska-Więckowicz, Anna, et al.
Publicado: (2021)

Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Esophageal Bullous Pemphigoid
por: Castelo Branco, Catarina, et al.
Publicado: (2022)

Dyshidrosiform Bullous Pemphigoid
por: Cohen, Philip R.
Publicado: (2021)

Commentary: Proinflammatory role of blister fluid-derived exosomes in bullous pemphigoid
por: Liu, Yangchun, et al.
Publicado: (2020)

Cutaneous Dermatophytosis Mimicking Bullous Pemphigoid or Typical Bullous Pemphigoid and Tinea Incognito?
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2019)

When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022)

A 50-year-old female with bullous pemphigoid
por: Wanjari, Mayur, et al.
Publicado: (2021)

Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023)

May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of Literature
por: Biondo, Michela Ileen, et al.
Publicado: (2021)

Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review
por: Chen, Xinyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qojv1o4mvqrnhb0e5e61us1c7u